ARTICLE | Clinical News
OMS201: Phase I data
January 5, 2009 8:00 AM UTC
In a double-blind, vehicle-controlled Phase I trial in patients undergoing endoscopic removal of urinary stones, OMS201 did not produce serious adverse events. Also, plasma levels of the active ingred...